Dashboard
Manage Tickers

SDGR


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

schrodinger-affirms-fy2025-sales-guidance-of-243440m-257460m-vs-249717m-est
Schrodinger Affirms FY2025 Sales Guidance ...
11/05/2025 21:14:36

Schrodinger (NASDAQ:SDGR) affirms FY2025 sales outlook from $243.440 million-$257.460 million to $243.440 million-$257.460 mill...

schrodinger-q3-adj-eps-057-beats-071-estimate-sales-54324m-beat-51557m-estimate
Schrodinger Q3 Adj. EPS $(0.57) Beats $(0....
11/05/2025 21:11:55

Schrodinger (NASDAQ:SDGR) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(0.71) b...

earnings-scheduled-for-november-5-2025
Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

Core News & Articles
10 Health Care Stocks Whale Activity In To...
11/03/2025 17:35:20

copernic-catalysts-surpasses-final-technical-milestone-for-its-jointly-developed-ammonia-synthesis-catalyst-with-schrodinger
Copernic Catalysts Surpasses Final Technic...
10/30/2025 11:38:52

Copernic Catalysts, Inc. (Copernic) today announced that, in collaboration with Schrödinger, Inc. (Nasdaq: SDGR), the companies...

keybanc-maintains-overweight-on-schrodinger-lowers-price-target-to-28
Keybanc Maintains Overweight on Schrodinge...
10/08/2025 13:16:48

Keybanc analyst Scott Schoenhaus maintains Schrodinger (NASDAQ:SDGR) with a Overweight and lowers the price target from $30 ...

expert-outlook-schrodinger-through-the-eyes-of-5-analysts
Expert Outlook: Schrodinger Through The Ey...
09/30/2025 14:01:44

goldman-sachs-initiates-coverage-on-schrodinger-with-neutral-rating-announces-price-target-of-19
Goldman Sachs Initiates Coverage On Schrod...
09/30/2025 12:37:50

Goldman Sachs analyst Andrea Newkirk initiates coverage on Schrodinger (NASDAQ:SDGR) with a Neutral rating and announces Pri...

schrdinger-announces-a-separation-and-release-of-claims-agreement-with-dr-geoffrey-porges-as-executive-vice-president-and-cfo
Schrödinger Announces A Separation And Rel...
09/08/2025 20:24:19

-SEC Filing-SEC Filing

what-4-analyst-ratings-have-to-say-about-schrodinger
What 4 Analyst Ratings Have To Say About S...
08/18/2025 21:03:03

morgan-stanley-maintains-equal-weight-on-schrodinger-lowers-price-target-to-19
Morgan Stanley Maintains Equal-Weight on S...
08/18/2025 13:49:45

Morgan Stanley analyst Vikram Malhorta maintains Schrodinger (NASDAQ:SDGR) with a Equal-Weight and lowers the price target f...

this-cisco-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-friday
This Cisco Analyst Is No Longer Bullish; H...
08/15/2025 14:53:07

citigroup-downgrades-schrodinger-to-neutral-lowers-price-target-to-20
Citigroup Downgrades Schrodinger to Neutra...
08/15/2025 10:54:49

Citigroup analyst David Lebowitz downgrades Schrodinger (NASDAQ:SDGR) from Buy to Neutral and lowers the price target from $...

this-azz-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday
This AZZ Analyst Begins Coverage On A Bull...
08/14/2025 17:11:47

schrdinger-discontinues-the-clinical-development-program-for-sgr-2921-which-was-being-evaluated-in-a-phase-1-dose-escalation-study-for-relapsedrefractory-acute-myeloid-leukemia-or-high-risk-myelodysplastic-syndromes-citing-two-patient-deaths
Schrödinger Discontinues The Clinical Deve...
08/14/2025 11:06:07

barclays-initiates-coverage-on-schrodinger-with-overweight-rating-announces-price-target-of-25
Barclays Initiates Coverage On Schrodinger...
08/14/2025 10:48:58

Barclays analyst Peter Lawson initiates coverage on Schrodinger (NASDAQ:SDGR) with a Overweight rating and announces Price T...

schrodinger-affirms-fy2025-sales-guidance-of-24344m-25746m-vs-25320m-est
Schrodinger Affirms FY2025 Sales Guidance ...
08/06/2025 21:04:35

Schrodinger (NASDAQ:SDGR) affirms FY2025 sales outlook from $243.44 million-$257.46 million to $243.44 million-$257.46 million ...

schrodinger-q2-adj-eps-065-beats-083-estimate-sales-5476m-beat-5203m-estimate
Schrodinger Q2 Adj. EPS $(0.65) Beats $(0....
08/06/2025 20:13:12

Schrodinger (NASDAQ:SDGR) reported quarterly losses of $(0.65) per share which beat the analyst consensus estimate of $(0.83) b...

Core News & Articles
Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

ajax-therapeutics-and-schrdinger-expand-research-collaboration-to-include-additional-jak-target
Ajax Therapeutics And Schrödinger Expand R...
07/17/2025 12:18:25

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION